Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Future Medicinal Chemistry
|
October 9, 2020
<i>In silico</i> identification and <i>in vitro</i> activity of natural products as ADP-ribosyl transferase member 8 inhibitors
Stephanie S Schweiker, Amanda L Tauber, Stephan M Levonis
Future Medicinal Chemistry
|
January 20, 2021
The potential association between PARP14 and SARS-CoV-2 infection (COVID-19)
Amanda L Tauber, Stephanie S Schweiker, Stephan M Levonis
Nutrition Research (New York, N.Y.)
|
January 10, 2020
From tea to treatment; epigallocatechin gallate and its potential involvement in minimizing the metabolic changes in cancer
Amanda L Tauber, Stephanie S Schweiker, Stephan M Levonis
Future Medicinal Chemistry
|
September 7, 2020
Recent developments in PARP14 research
Amanda L Tauber, Stephan M Levonis, Stephanie S Schweiker
Future Medicinal Chemistry
|
February 3, 2023
The connection between PARP14 and SARS-CoV-2
Amanda L Tauber, Stephanie S Schweiker, Stephan M Levonis
Future Medicinal Chemistry
|
November 23, 2020
Design, synthesis and evaluation of potential inhibitors for poly(ADP-ribose) polymerase members 1 and 14
Caleb M Kam, Amanda L Tauber, Stephan M Levonis, et al.
Mini Reviews in Medicinal Chemistry
|
August 17, 2018
Structure, Function and Inhibition of Poly(ADP-ribose)polymerase, Member 14 (PARP14)
Stephanie S Schweiker, Amanda L Tauber, Madeleine E Sherry, et al.
Future Medicinal Chemistry
|
November 23, 2020
<i>In silico</i> family-wide profiling and 3D modelling of the poly(ADP-ribose) polymerase superfamily
Caleb M Kam, Amanda L Tauber, Dean L Oosthuizen, et al.
Future Medicinal Chemistry
|
December 18, 2024
Novel inhibitors of PARP1 and PARP14: design, synthesis, and potentiation of cisplatin efficacy in cancer
Caleb M T Kam, Amanda L Tauber, Matthew S Zunk, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Future Medicinal Chemistry
|
October 9, 2020
<i>In silico</i> identification and <i>in vitro</i> activity of natural products as ADP-ribosyl transferase member 8 inhibitors
Stephanie S Schweiker, Amanda L Tauber, Stephan M Levonis
Future Medicinal Chemistry
|
January 20, 2021
The potential association between PARP14 and SARS-CoV-2 infection (COVID-19)
Amanda L Tauber, Stephanie S Schweiker, Stephan M Levonis
Nutrition Research (New York, N.Y.)
|
January 10, 2020
From tea to treatment; epigallocatechin gallate and its potential involvement in minimizing the metabolic changes in cancer
Amanda L Tauber, Stephanie S Schweiker, Stephan M Levonis
Future Medicinal Chemistry
|
September 7, 2020
Recent developments in PARP14 research
Amanda L Tauber, Stephan M Levonis, Stephanie S Schweiker
Future Medicinal Chemistry
|
February 3, 2023
The connection between PARP14 and SARS-CoV-2
Amanda L Tauber, Stephanie S Schweiker, Stephan M Levonis
Future Medicinal Chemistry
|
November 23, 2020
Design, synthesis and evaluation of potential inhibitors for poly(ADP-ribose) polymerase members 1 and 14
Caleb M Kam, Amanda L Tauber, Stephan M Levonis, et al.
Mini Reviews in Medicinal Chemistry
|
August 17, 2018
Structure, Function and Inhibition of Poly(ADP-ribose)polymerase, Member 14 (PARP14)
Stephanie S Schweiker, Amanda L Tauber, Madeleine E Sherry, et al.
Future Medicinal Chemistry
|
November 23, 2020
<i>In silico</i> family-wide profiling and 3D modelling of the poly(ADP-ribose) polymerase superfamily
Caleb M Kam, Amanda L Tauber, Dean L Oosthuizen, et al.
Future Medicinal Chemistry
|
December 18, 2024
Novel inhibitors of PARP1 and PARP14: design, synthesis, and potentiation of cisplatin efficacy in cancer
Caleb M T Kam, Amanda L Tauber, Matthew S Zunk, et al.
Page
of 1